Structure and Interactions of the Human Programmed Cell Death 1 Receptor

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m112.448126
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Human Immunodeficiency Virus 1 Envelope-Initiated G2-Phase Programmed Cell Death.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1995English

Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy

JAMA Dermatology
DermatologyMedicine
2016English

Apoptosis: Programmed Cell Death

Archives of Surgery
1998English

Programmed Cell Death-1/Programmed Death-Ligand 1 Blockade Improves Survival of Animals With Sepsis: A Systematic Review and Meta-Analysis

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Apoptosis (Programmed Cell Death)

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
1995English

Apoptosis, Programmed Cell Death

2013English

Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1

Clinical Cancer Research
Cancer ResearchOncology
2012English

PD-1 Receptor (PDCD1; PD-1; CD279); Programmed Cell Death 1 Ligand 1 (CD274 Molecule; PD-L1; B7-H1)

Science-Business eXchange
2010English

Diverse Cutaneous Adverse Eruptions Caused by Anti-Programmed Cell Death-1 (PD-1) and Anti-Programmed Cell Death Ligand-1 (PD-L1) Immunotherapies: Clinical Features and Management

Therapeutic Advances in Medical Oncology
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy